Zi Hui

Hangzhou, 311121, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Correction to "Design and Synthesis of Pyrrolo[3,4-d]pyrimidine-Based ATR Degraders for Effective Treatment of Colorectal Cancer in Mouse Model".

Correction to "Design and Synthesis of Pyrrolo[3,4-d]pyrimidine-Based ATR Degraders for Effective Treatment of Colorectal Cancer in Mouse Model".

Journal: Journal of medicinal chemistry

Published: March 28, 2026

Design and Synthesis of Pyrrolo[3,4-d]pyrimidine-Based ATR Degraders for Effective Treatment of Colorectal Cancer in Mouse Model.

Design and Synthesis of Pyrrolo[3,4-d]pyrimidine-Based ATR Degraders for Effective Treatment of Colorectal Cancer in Mouse Model.

Journal: Journal of medicinal chemistry

Published: March 06, 2026

Anticancer natural products derived from fungi: A review of promising lead compounds.

Anticancer natural products derived from fungi: A review of promising lead compounds.

Journal: European journal of medicinal chemistry

Published: December 24, 2025

Design, synthesis, and biological evaluation of aminopyrazine-based ATR/HDACs dual inhibitors.

Design, synthesis, and biological evaluation of aminopyrazine-based ATR/HDACs dual inhibitors.

Journal: Molecular diversity

Published: April 14, 2025

A novel PARP-ATR dual inhibitor exhibits anti-triple-negative breast cancer activity by inducing excessive DNA damage in the mitotic phase.

A novel PARP-ATR dual inhibitor exhibits anti-triple-negative breast cancer activity by inducing excessive DNA damage in the mitotic phase.

Journal: Biochemical pharmacology

Published: March 25, 2025

Updated patent review for hematopoietic progenitor kinase (HPK1) inhibitors and degraders (2021-present).

Updated patent review for hematopoietic progenitor kinase (HPK1) inhibitors and degraders (2021-present).

Journal: Expert opinion on therapeutic patents

Published: February 14, 2025

Modular assembly and evaluation of a TROP2-targeting immunotoxin for cancer therapy.

Modular assembly and evaluation of a TROP2-targeting immunotoxin for cancer therapy.

Journal: International journal of biological macromolecules

Published: January 27, 2025

Discovery and optimization of AAK1 inhibitors based on 1H-indazole scaffold for the potential treatment of SARS-CoV-2 infection.

Discovery and optimization of AAK1 inhibitors based on 1H-indazole scaffold for the potential treatment of SARS-CoV-2 infection.

Journal: Molecular diversity

Published: January 04, 2025

Design, synthesis, and biological evaluation of novel AAK1/HDACs dual inhibitors against SARS-CoV-2 entry.

Design, synthesis, and biological evaluation of novel AAK1/HDACs dual inhibitors against SARS-CoV-2 entry.

Journal: Bioorganic chemistry

Published: June 11, 2024

Development and therapeutic potential of DNA-dependent protein kinase inhibitors.

Development and therapeutic potential of DNA-dependent protein kinase inhibitors.

Journal: Bioorganic chemistry

Published: May 04, 2024

Design, Synthesis, and Structure-Activity Relationship of Novel Pyridazinone-Based PARP7/HDACs Dual Inhibitors for Elucidating the Relationship between Antitumor Immunity and HDACs Inhibition.

Design, Synthesis, and Structure-Activity Relationship of Novel Pyridazinone-Based PARP7/HDACs Dual Inhibitors for Elucidating the Relationship between Antitumor Immunity and HDACs Inhibition.

Journal: Journal of medicinal chemistry

Published: March 08, 2024

Prevention and Potential Treatment Strategies for Respiratory Syncytial Virus.

Prevention and Potential Treatment Strategies for Respiratory Syncytial Virus.

Journal: Molecules (Basel, Switzerland)

Published: December 17, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026